MICHELLE ALLEN: Open Payments
NPI 1902907561 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 20 payments from 11 companies in 2025. Trend: 2023 $496 · 2024 $487 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 3 | $65 |
| Amgen Inc. | 4 | $60 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $40 |
| ABBVIE INC. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: EVENITY, Veozah, VRAYLAR, GEMTESA, Mirena, Dexcom G6 Transmitter, PROQUAD, MYFEMBREE.
Industry payments across MO — which companies pay providers there.
